AKERS BIOSCIENCES INC's ticker is AKER and the CUSIP is 00973E102. A total of 15 filers reported holding AKERS BIOSCIENCES INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $3,000 | -88.0% | 10,343 | -84.1% | 0.00% | – |
Q2 2018 | $25,000 | -53.7% | 64,964 | -0.0% | 0.00% | – |
Q1 2018 | $54,000 | +500.0% | 64,965 | 0.0% | 0.00% | – |
Q4 2017 | $9,000 | -83.0% | 64,965 | 0.0% | 0.00% | – |
Q3 2017 | $53,000 | -35.4% | 64,965 | -0.5% | 0.00% | – |
Q2 2017 | $82,000 | -30.5% | 65,284 | 0.0% | 0.00% | – |
Q1 2017 | $118,000 | -4.8% | 65,284 | 0.0% | 0.00% | – |
Q4 2016 | $124,000 | -43.4% | 65,284 | 0.0% | 0.00% | – |
Q3 2016 | $219,000 | +4.3% | 65,284 | 0.0% | 0.00% | – |
Q2 2016 | $210,000 | +90.9% | 65,284 | 0.0% | 0.00% | – |
Q1 2016 | $110,000 | +39.2% | 65,284 | 0.0% | 0.00% | – |
Q4 2015 | $79,000 | -61.7% | 65,284 | 0.0% | 0.00% | – |
Q3 2015 | $206,000 | -27.5% | 65,284 | 0.0% | 0.00% | – |
Q2 2015 | $284,000 | +2.5% | 65,284 | 0.0% | 0.00% | – |
Q1 2015 | $277,000 | +6.5% | 65,284 | 0.0% | 0.00% | – |
Q4 2014 | $260,000 | +10.6% | 65,284 | 0.0% | 0.00% | – |
Q3 2014 | $235,000 | -15.5% | 65,284 | 0.0% | 0.00% | – |
Q2 2014 | $278,000 | -6.7% | 65,284 | 0.0% | 0.00% | – |
Q1 2014 | $298,000 | – | 65,284 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
PERKINS CAPITAL MANAGEMENT INC | 95,700 | $408,000 | 0.29% |
BARD ASSOCIATES INC | 90,000 | $383,000 | 0.15% |
LMR Partners LLP | 136,342 | $574,000 | 0.05% |
COMMERZBANK AKTIENGESELLSCHAFT /FI | 83,655 | $356,000 | 0.00% |
OPPENHEIMER & CO INC | 10,700 | $46,000 | 0.00% |
Tower Research Capital LLC (TRC) | 1,921 | $8,000 | 0.00% |
AMERICAN INTERNATIONAL GROUP, INC. | 500 | $2,130,000 | 0.00% |
BANK OF AMERICA CORP /DE/ | 1,605 | $7,000 | 0.00% |
PNC FINANCIAL SERVICES GROUP, INC. | 2,005 | $9,000 | 0.00% |
WELLS FARGO & COMPANY/MN | 200 | $1,000 | 0.00% |